Skip to main content

Table 2 Summary of studies included into meta-analysis

From: Relationship between ABCB1 3435TT genotype and antiepileptic drugs resistance in Epilepsy: updated systematic review and meta-analysis

Polymorphism

Genotype Model

Ethnicity

Total No.

Male %/Female %

Mean Age (years)

Aetiology of epilepsy

Type of epilepsy

AEDs

Reference

ABCB1

c.3435C>T

CC vs. TT

Chinese

Cases

331

56.193/43.807

39.1±11 a

Cryptogenic

Generalized, partial

–

Hung et al., 2005 [22]

38.5±13.4 b

Cryptogenic, idiopathic

Controls

–

–

–

–

–

–

Cases

331

–

40.11±11 a

Cryptogenic

Generalized, partial

CBZ, CNZ, GBP, LTG, OXC, PB, PHT, TPM, VGB, VPA

Hung et al., 2007 [23]

39.5±13.4 b

Cryptogenic, idiopathic

 

Controls

287

–

41±10.9

–

–

–

Egyptian

Cases

100

56 /44

35.9 ±8.42

–

Generalized, partial

PHT a

Ebid et al., 2007 [24]

Controls

50

64/36

38.6±10.32

–

–

–

European

Cases

289

49.827/50.173

27.0 ±18.5 a

26.0 ±19.8 b

Various d

Generalized, partial

–

Sánchez et al., 2010 [31]

Controls

–

–

–

–

–

–

Cases

315

–

–

–

Generalized, partial

–

Siddiqui et al., 2003 [25]

Controls

200

–

–

–

–

–

Cases

173

50.289/49.711

8.5±4.84 a

8.2±4.019 b

–

–

CBZ, GBP, LEV, LTG,

OXC, TPM

Stasiołek et al., 2016 [26]

Controls

98

53.061/46.939

8.3±4.64

–

–

–

Indian

Cases

115

73.215/26.786

34.69±10.06 a

38.02±11.46 b

–

–

CBZ, PB, PHT

Taur et al., 2014 [27]

Controls

–

–

–

–

–

–

Iranian

Cases

332

52.711/47.289

28.8±11 a

27±13 b

Various d

Generalized, partial

CBZ, CNZ, LEV, LTG, OXC, PB, PHT, PRI, TPM, VPA

Sayyah et al., 2011 [28]

Controls

–

–

–

–

–

–

Thai

Cases

110

52.727/47.273

41.96 ±12.19 a

46.65±12.65 b

–

Generalized, partial

CBZ, PB, PHT, VPA

Keangpraphun et al., 2015 [29]

Controls

–

–

–

–

–

–

ABCB1

c.3435C>T

TT vs. CC

Australian

Cases

609

–

–

–

Generalized, partial

–

Tan et al., 2004 [33]

Controls

–

–

–

–

–

–

Chinese

Cases

746

–

–

Various d

–

–

Kwan et al., 2007 [34]

Controls

–

–

–

–

–

–

Indian

Cases

220

65.455/34.545

8.1±2.47 e

38.3±12.2 f

Various d

Generalized, partial

CBZ, CLB, LEV, OXC, PHT, VPA

Shaheen et al., 2013 [35]

Controls

220

65.455/34.545

10.5±4.5 e

37±10 f

–

–

–

Japanese

Cases

210

56.667/43.333

18.0±9.6 a

16.5±9.5 b

Various d

Generalized, partial

AZA, CBZ, CLB, CNZ, DZP, ESM, Ethotoin, NTZ, PB, PHT, VPA, ZNS

Seo et al., 2006 [36]

Controls

–

–

–

–

–

–

  1. Abbreviation: AEDs anti-epileptic drugs, ABCB1 atp-binding cassette sub-family b member 1, AZA acetazolamide, CBZ carbamazepine, CLB clobazam, CNZ clonazepam, DZP diazepam, ESM ethosuximide, GBP gabapentin, LEV levetiracetam, LTG lamotrigine, NTZ nitrozepam, OXC oxcarbazepine, PB phenobarbital, PHT phenytoin, PRI primidone, TPM topiramate, VGB vigabatrin, VPA valproate, ZNS zonisamide, − = no data, a AEDs-resistant cases, b AEDs-responsive cases, c Administration of PHT as monotherapy or polytherapy was not mentioned, d Idiopathic, cryptogenic, symptomatic, e <15 years, f >15 years